|
MFF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.40802991067358E-13 |
| Normal-vs-Stage2 |
1.53610000275251E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
4.39109859584619E-11 |
| Stage1-vs-Stage2 |
7.395200E-01 |
| Stage1-vs-Stage3 |
2.261000E-03 |
| Stage1-vs-Stage4 |
4.521400E-01 |
| Stage2-vs-Stage3 |
6.310000E-02 |
| Stage2-vs-Stage4 |
7.909400E-01 |
| Stage3-vs-Stage4 |
7.414500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.86832999999886E-05 |
| Normal-vs-Asian |
2.646500E-04 |
| Caucasian-vs-AfricanAmerican |
1.123200E-01 |
| Caucasian-vs-Asian |
4.601400E-01 |
| AfricanAmerican-vs-Asian |
2.484000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.00639996336582E-09 |
| Male-vs-Female |
1.655340E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.58319998514401E-09 |
| Normal-vs-Age(41-60Yrs) |
1.64634972321664E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(81-100Yrs) |
1.52863999999253E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.941790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.906000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.119200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.405200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.832200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.041000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.452200E-01 |
| Normal-vs-Grade 2 |
4.67270666604236E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.63735691671718E-12 |
| Grade 1-vs-Grade 2 |
4.935600E-01 |
| Grade 1-vs-Grade 3 |
2.829800E-01 |
| Grade 1-vs-Grade 4 |
1.585760E-01 |
| Grade 2-vs-Grade 3 |
2.369900E-02 |
| Grade 2-vs-Grade 4 |
2.757300E-03 |
| Grade 3-vs-Grade 4 |
1.080630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.36062338752208E-12 |
| Normal-vs-ccB subtype |
1.6242562850266E-12 |
| ccA subtype-vs-ccB subtype |
1.95084999999873E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62980740014973E-12 |
| Normal-vs-N1 |
2.24479999999527E-05 |
| N0-vs-N1 |
6.520200E-01 |
|
|
